Cancer immunotherapy has already transformed treatment for some patients, yet too often the body’s defenders stall out before ...

ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, today announced that it has entered into a collaboration agreement with Fosun Kairos ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

Pitavastatin, a cholesterol lowering drug, slashes chemotherapy resistance in breast cancer by obstructing a specific protein ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

Biologist Eduard Batlle used to spend his weekends at his parents’ confectionery. Now he’s one of the six inventors of ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

These days, college football recruiting is more about the money the athletes can now make in what has become a semi-pro ...

DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.

Scientists at EPFL and Johns Hopkins uncover the central role of an enzyme in controlling prostate cancer subtypes and ...

New research has shown how brain cells acquire a cancerous mutation and spread across the cortex, opening a new path for ...